『2 Minutes with Joey - RXRX Stock News』のカバーアート

2 Minutes with Joey - RXRX Stock News

2 Minutes with Joey - RXRX Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Recursion (RXRX) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • RXRX Today - Aug 13: Slight Uptick in Value

    RXRX Today - Aug 13: Slight Uptick in Value
    2026/08/13
    Hey there! It’s Joey, your friendly neighborhood investor, here to break down today’s stock action. We’re talking about Recursion, ticker RXRX. It was a green day for them, up just a smidge—about 0.6 percent. Not a huge leap, but hey, green is good, right?

    So, what went down? The stock kinda cruised along today, with some decent volume but not really popping off. It opened around 3.27 and climbed a bit to finish at 3.31. Nothing too crazy, but it’s nice to see it in the green rather than red, you know?

    Now, why did it move like this? Well, there’s some chatter about Recursion hitting an inflection point, according to their CEO. That’s a fancy way of saying they might be turning a corner on their growth or pipeline. They had some good news about their Q4 performance, which got people a bit excited in pre-market trading. But then, it kinda settled down once the day rolled on. Plus, there’s some interesting stuff happening with options trading—people are buying a lot of put options, which usually means they’re hedging against a potential drop. So, yeah, there’s a mix of optimism and caution in the air.

    And just a heads-up, Recursion did file a notice about a proposed sale of securities. That’s just a formality, but it can sometimes make investors a little twitchy. It’s like, “What’s the plan here?”

    To wrap it up, RXRX had a slightly positive day with some potential good vibes about their future, but there’s also a bit of unease with those put options floating around. Just keep your eyes peeled, folks. Remember, I’m just here sharing what I see, not giving any financial advice. Catch you later!
    続きを読む 一部表示
    2 分
  • RXRX Today - Aug 12: Short Interest Rises

    RXRX Today - Aug 12: Short Interest Rises
    2026/08/12
    Hey there! It’s Joey here, your go-to guy for stock chat. I’ve been in the investing game for a while now, and today we're talking about Recursion, ticker RXRX. Spoiler alert: it was a red day for them, down about 1.6%.

    So, what happened? Recursion got smoked today. The stock took a hit, and it seems like traders were feeling pretty nervous. There was a lot of chatter about short interest rising to over 35%. That’s a big deal! When more people are betting against a stock, it can really shake things up. Plus, I saw some reports about folks buying up put options, which kinda signals that people were expecting more downside. Not a great vibe for the bulls.

    Now, why did this happen? Well, it looks like there’s some concern about Recursion's growth. They’ve been pushing hard on their AI drug discovery partnerships, but even with that, they’re facing a cash burn and slow growth. That can freak investors out. Plus, there was some bearish sentiment floating around in the air, especially after a recent article pointed out that even with the Genentech news, there’s still a lot of skepticism about Recursion's future. Yeah, that one stung.

    On the horizon, there’s a notice of proposed sale of securities under Rule 144. That could mean they’re looking to raise some cash, which is worth keeping an eye on. It’s like, more dilution might be coming down the line, and nobody loves that.

    So, to wrap it up, Recursion had a tough day with a lot of noise about short selling and concerns over their growth strategy. It’s a wild ride in the biotech space, and RXRX is right in the middle of it. Just remember, this is all for fun and info—no financial advice here. Catch you later!
    続きを読む 一部表示
    2 分
  • RXRX Today - Aug 11: Analysts Trim Revenue Forecasts

    RXRX Today - Aug 11: Analysts Trim Revenue Forecasts
    2026/08/11
    Hey, what’s up? It’s Joey here, your friendly neighborhood investor, breaking down the day for you. Today, we’re chatting about Recursion, RXRX. It was a bit of a mixed bag, but overall, it ended up in the green, gaining about 1.4%. Not a huge move, but hey, at least it didn’t get smoked, right?

    So, here’s the scoop. RXRX had a pretty chill trading day with decent volume, but there’s a lot more going on behind the scenes. The stock’s been buzzing with some mixed news lately. On one hand, there’s been chatter about their partnerships in AI drug discovery, which sounds cool and all, but the reality is that they’re facing some serious cash burn and slow growth. Not exactly the vibes you want when you’re trying to boost a stock’s value.

    Now, let’s talk about why the stock moved today. Analysts just trimmed their revenue forecasts for Recursion by a whopping 19%. Ouch! That definitely got some folks worried. When analysts start cutting estimates like that, it usually sends investors scrambling for the exit. Plus, there’s chatter about a proposed sale of securities, which can make people a bit uneasy. It’s like, “What do they know that we don’t?”

    And speaking of uncertainty, Recursion’s earnings call just dropped, and while they had some news, it didn’t exactly light the world on fire. Investors are still feeling the heat from all these mixed signals. So yeah, people are definitely on edge with RXRX right now.

    One thing to keep an eye on is how these partnerships in AI drug discovery pan out. They’ve got potential, but if Recursion can’t get a handle on that cash burn, it might be a rough ride.

    Alright, that’s a wrap for today! Just a heads up, this is all for your info and entertainment—no financial advice here. Catch you later!
    続きを読む 一部表示
    2 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません